-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 13, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GMar 12, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 9, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 1, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 1, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 23, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 22, 2012View HTMLDownload DOCDownload PDFDownload XLS
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 22, 2012View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventFeb 16, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2012View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2012View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2012View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 9, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 6, 2012View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-154

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information